Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
KRYS | Krystal Biotech, Inc. | NORBY R DOUGLAS | Director | May 09, 2018 | Buy | $10.42 | 9,000 | 93,780 | 9,000 | May 11, 2018, 04:27 PM | |
ALXN | ALEXION PHARMACEUTICALS INC | NORBY R DOUGLAS | Director | Sep 23, 2016 | Option Exercise | $129.94 | 15,500 | 2,014,105 | 11,174 | Sep 27, 2016, 05:14 PM | |
ALXN | ALEXION PHARMACEUTICALS INC | NORBY R DOUGLAS | Director | Dec 11, 2015 | Option Exercise | $110.75 | 90,884 | 10,065,163 | 77,923 | Dec 15, 2015, 05:36 PM | |
ALXN | ALEXION PHARMACEUTICALS INC | NORBY R DOUGLAS | Director | May 22, 2013 | Sale | $58.33 | 80,000 | 4,666,202 | 96,144 | May 23, 2013, 05:03 PM | |
ALXN | ALEXION PHARMACEUTICALS INC | NORBY R DOUGLAS | Director | Dec 10, 2012 | Sale | $49.91 | 44,000 | 2,195,830 | 60,673 | Dec 12, 2012, 06:19 PM | |
ALXN | ALEXION PHARMACEUTICALS INC | NORBY R DOUGLAS | Director | Mar 08, 2012 | Sale | $46.59 | 3,400 | 158,406 | 32,443 | Mar 12, 2012, 05:14 PM | |
ALXN | ALEXION PHARMACEUTICALS INC | NORBY R DOUGLAS | Director | Mar 09, 2012 | Option Exercise | $46.60 | 56,600 | 2,637,277 | 59,043 | Mar 12, 2012, 05:14 PM | |
ALXN | ALEXION PHARMACEUTICALS INC | NORBY R DOUGLAS | Director | Oct 27, 2011 | Option Exercise | $36.78 | 37,760 | 1,388,624 | 46,508 | Oct 31, 2011, 05:11 PM | |
ALXN | ALEXION PHARMACEUTICALS INC | NORBY R DOUGLAS | Director | Oct 28, 2011 | Sale | $36.60 | 52,240 | 1,911,826 | 53,748 | Oct 31, 2011, 05:11 PM | |
ALXN | ALEXION PHARMACEUTICALS INC | NORBY R DOUGLAS | Director | Feb 14, 2011 | Option Exercise | $48.68 | 46,000 | 2,239,300 | 36,814 | Feb 16, 2011, 04:28 PM |